SIMEPREVIR (TMC435) WITH PEGINTERFERON/RIBAVIRIN FOR TREATMENT OF CHRONIC HCV GENOTYPE-1 INFECTION IN TREATMENT-NAIVE PATIENTS: RESULTS FROM QUEST-2, A PHASE III TRIAL

Authors
Category Primary study
JournalJOURNAL OF HEPATOLOGY
Year 2013
This article has no abstract
Epistemonikos ID: fcd022d1ff3a70f489aada7b81a01218ab5a2e77
First added on: Jan 05, 2026